Rational treatment of benign prostatic hyperplasia: efficacy of long-term treatment with dutasteride
- Authors: Tkachuk V.N1, Borovets S.Y.1, Tkachuk I.N1, Iziev M.M1
-
Affiliations:
- I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 18, No 7 (2016)
- Pages: 19-21
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94530
- ID: 94530
Cite item
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
V. N Tkachuk
I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation
Email: iakorneyev@yandex.ru
д-р мед. наук, проф. каф. урологии ГБОУ ВПО Первый СПбГМУ им. акад. И.П.Павлов 197022, Russian Federation, Saint Petersburg, ul. L'va Tolstogo, d. 6/8
S. Yu Borovets
I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federationд-р мед. наук, ст. науч. сотр. каф. урологии ГБОУ ВПО Первый СПбГМУ им. акад. И.П.Павлова 197022, Russian Federation, Saint Petersburg, ul. L'va Tolstogo, d. 6/8
I. N Tkachuk
I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. урологии ГБОУ ВПО Первый СПбГМУ им. акад. И.П.Павлова 197022, Russian Federation, Saint Petersburg, ul. L'va Tolstogo, d. 6/8
M. M Iziev
I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federationаспирант каф. урологии ГБОУ ВПО Первый СПбГМУ им. акад. И.П.Павлова 197022, Russian Federation, Saint Petersburg, ul. L'va Tolstogo, d. 6/8
References
- Ткачук В.Н. Медикаментозное лечение доброкачественной гиперплазии предстательной железы. Медицина для всех. М., 2009; 1-128.
- Gravas S, Bach T, Bachmann A et al. Guidelines on the management of non - neurogenic male lower urinary tract symptoms. Benign prostatic obstruction. European Association of Urology. Guidelines 2015; 3: 1-61.
- Han L. Association of physicion speciality and medical therapy for BPH. Med Care 2014; 52 (2): 128-36.
- Cindolo L. Efficacy and safety of dutasteride for the treatment of BPH. World J Urol 2015; 33 (3): 441-2.
- Ткачук В.Н., Изиев М.М. Оценка эффективности и безопасности длительной терапии дутастеридом больных с доброкачественной гиперплазией предстательной железы. Нефрология. 2016; 20 (1): 63-8.
- Roehrloen C. The effects of combinatia therapy with dutasteride and tamsulasin in men with BPH: 4-year results from the combat study. Eur Urol 2010; 57 (1): 123-31.
- Debruyne F, Barkin J, van Erps P et al. ARIA - 3001, ARIA - 3002 study investigators. Efficacy and safety of long term treatment with the dual 5a - reductase inhibitor dutasteride in men with BPH. Eur Urol 2004; 46: 488-94.
- Park T, Choi J. Efficacy and safety of dutasteride for the treatment of BPH. World J Urol 2014; 32 (4): 1093-105.
- Toren P, Margel D, Zlotta A et al. Effect of dutasteride on clinical progression of BPH. Br Med J 2013; 346: 2109-12.
Supplementary files
